logo
Select company
Select metric
34.5Price to Earnings
VS
Market
26
Sector
32
Industry
25
History
62
$ 6.06Close
$ 3.53 - $ 7.6 52-Week Range
Ticker Information

Ticker

ICCC

Company Name

IMMUCELL CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

IMMUCELL CORP - Price to Earnings Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ICCC - P/E Historical data
DateMarket CapitalizationNet Income Common StockPrice to Earnings
6/30/2025$ 60.79M$ 1.76M34.5
3/31/2025$ 44.37M$ -271.78K0
12/31/2024$ 45M$ -2.16M0
9/30/2024$ 31.46M$ -3.81M0
6/30/2024$ 29.45M$ -4.05M0
3/31/2024$ 42.78M$ -3.9M0
12/31/2023$ 40.38M$ -5.77M0
9/30/2023$ 40.3M$ -6.3M0
6/30/2023$ 38.89M$ -6.02M0
3/31/2023$ 38.42M$ -5.32M0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Price to Earnings

[Calculation] Measures a company’s [MarketCap] in relation to its Net Income [NetIncCmn]. A high P/E ratio indicates that investors anticipate greater future earnings growth compared to companies with a lower P/E.
Market Cap / Net Inc. Cmn.
(=) P/E
P/E for IMMUCELL CORP is calculated as follows: Market Cap [ $ 40.97M ] / Net Inc. Cmn. [ $ -1.52M ]
(=) P/E [ 0 ]

ICCC - Price to Earnings, Last 5 years

34.5

Minimum

Jun 30, 2025

1.96K

Maximum

Sep 30, 2021

573.48

Average

151.44

Median

P/E Benchmark Analysis

The chart above depicts the distribution of P/E for companies in the Total Stock Market. The average P/E of the companies is 22.52 with a standard deviation of 13.96.
The following table provides additional summary stats:
P/E in the Market:
filtered constituents2.08K
min0.13
max70.11
average22.52
median18.89
std13.96